Should I Buy NIVF? NIVF 2026 Analysis

Should You Buy NewGenIvf Group Ltd (NIVF) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

1.580

1 Day change

5.67%

52 Week Range

4125.000

Analysis Updated At

2026/01/26

NewGenIVF Group Ltd is not a good buy for a beginner, long-term investor at this time. The company's recent financial performance shows significant declines, the technical indicators suggest a bearish trend, and there are no strong positive trading signals or catalysts to support an immediate investment.

Technical Analysis

The MACD is slightly positive, but the RSI is neutral, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 0.519, with resistance at 0.621 and support at 0.416. Overall, the technical indicators suggest a weak and uncertain price trend.

Options Data

Positive Catalysts

The company is planning a $30 million tokenized bond issuance in Q1 2026, which could increase total assets by $28 million. Collaboration with Evident Capital aims to strengthen its position in the digital asset space.

Neutral/Negative Catalysts

The company's financials for 2025/Q3 show significant declines in revenue (-12.94% YoY), net income (-84822.54% YoY), EPS (-2093.67% YoY), and gross margin (-79.11% YoY). Additionally, hedge funds and insiders are neutral, with no significant trading trends.

Financial Performance

In 2025/Q3, the company experienced a sharp decline in financial metrics: Revenue dropped to 1,282,251 (-12.94% YoY), Net Income dropped to 16,823,355 (-84822.54% YoY), EPS dropped to 195.38 (-2093.67% YoY), and Gross Margin dropped to 9.2 (-79.11% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target changes were provided.

Analyst Rating

Wall Street analysts forecast NIVF stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NIVF is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 1.500

Low

Averages

High